TGFB1 and cancer: Since TGFβ signaling responses can be supportive of events that support malignant progression such as EMT and suppression of TGFβ signaling as a therapy for cancer has been supported by experimental evidence, therapeutic strategies for the inhibition of TGFβ signaling in cancer therapy are currently being pursued.